文献速递呼吸道感染呼吸危重症与机械通气

脓毒症初始静脉补液量与呼吸衰竭风险的回顾性分析:SAIFR研究

Sepsis, the Administration of IV Fluids, and Respiratory Failure: A Retrospective Analysis-SAIFR Study.
PubMed 文献 · Chest · 2020-11-14

该单中心回顾性分析纳入2017年6月至2018年6月收治的214例脓毒症患者,按是否接受指南推荐的30 mL/kg及以上初始液体复苏分组。

要点

  • 接受指南推荐30 mL/kg及以上初始补液与保守补液者呼吸衰竭发生率无显著差异
  • 充血性心力衰竭和慢性肾脏病高危亚组结果与总体一致

核心结论

  • 在单中心回顾性分析中,以氧需求增加宽泛定义呼吸衰竭时,保守的初始静脉液体复苏策略未与低氧性呼吸衰竭发生率下降相关。

研究设计与样本

  • 研究为在內布拉斯加州奥马哈一家学术医学中心开展的单中心回顾性分析,数据来自前瞻性收集的临床资料。
  • 共纳入2017年6月至2018年6月间收治的214例脓毒症患者,按是否接受指南推荐的初始液体推注进行分层。

主要发现

  • 214例中62例(29.0%)接受了适当的初始液体推注治疗。
  • 充血性心力衰竭与慢性肾脏病高危亚组内的结果与总体相似。

关键数值与推荐

  • 指南推荐的初始静脉液体推注量为30 mL/kg及以上,保守复苏定义为小于30 mL/kg。
  • 呼吸衰竭定义为氧流量增加或需要更强化的氧疗与通气支持,氧需求与容量在入院、6 h、12 h、24 h及出院时测量。

临床怎么用

  • 对于脓毒症患者,在关注低氧性呼吸衰竭风险时,尚不能仅凭是否达到30 mL/kg初始补液量判断呼吸衰竭风险高低。

局限性

  • 本研究为单中心回顾性分析,样本量214例,结果外推需谨慎。
  • 呼吸衰竭采用氧需求增加的宽泛定义,可能影响与其他研究的可比性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although resuscitation with IV fluids is the cornerstone of sepsis management, consensus regarding their association with improvement in clinical outcomes is lacking. RESEARCH QUESTION: Is there a difference in the incidence of respiratory failure in patients with sepsis who received guideline-recommended initial IV fluid bolus of 30 mL/kg or more conservative resuscitation of less than 30 mL/kg? STUDY DESIGN AND METHODS: This was a retrospective analysis of prospectively collected clinical data conducted at an academic medical center in Omaha, Nebraska. We abstracted data from 214 patients with sepsis admitted to a single academic medical center between June 2017 and June 2018. Patients were stratified by receipt of guideline-recommended fluid bolus. The primary outcome was respiratory failure defined as an increase in oxygen flow rate or more intense oxygenation and ventilation support; oxygen requirement and volume were measured at admission, 6 h, 12 h, 24 h, and at discharge. Subgroup analyses were conducted in high-risk patients with congestive heart failure (CHF) as well as those with chronic kidney disease (CKD). RESULTS: A total of 62 patients (29.0%) received appropriate bolus treatment. The overall rate of respiratory failure was not statistically different between patients who received appropriate bolus or did not (40.3% vs 36.8%; P = .634). Likewise, no differences were observed in time to respiratory failure (P = .645) or risk of respiratory failure (adjusted hazard ratio, 1.1 [95% CI, 0.7-1.7]; P = .774). Results were similar within the high-risk CHF and CKD subgroups. INTERPRETATION: In this single-center retrospective study, we found that by broadly defining respiratory failure as an increase in oxygen requirements, a conservative initial IV fluid resuscitation strategy did not correlate with decreased rates of hypoxemic respiratory failure.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Jagan N, Morrow LE, Walters RW, et al. Sepsis, the Administration of IV Fluids, and Respiratory Failure: A Retrospective Analysis-SAIFR Study. Chest. 2020. PMID: 33197405. doi:10.1016/j.chest.2020.10.078

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。